Key Market Indicator:
Ad-hoc news is mandatory information from listed companies that must be made available to investors. Depending on the occasion and content of the news, it can have an impact on the share price. The newsfeed covers a wide range of topics relevant to investor relations and is recommended as an important source of information before making an investment decision.
NL0012768675
Wed, 31.05.2023
IGEA Pharma N.V.
IGEA to apply for a further extension of its disclosure obligations
Hoofddorp, the Netherlands, 31 May 2023. IGEA Pharma N.V. (SIX: IGPH) today announced the submission of a further exemption application to the SIX.
The exemption application, dated 31 May 2023, requests an extension of the deadline to publish IGEA’s 2022 annual rep [ … ]
Tue, 30.05.2023
IGEA Pharma N.V.
IGEA to update on strategic refocusing decisions.
Hoofddorp, the Netherlands, 30 May 2023. IGEA Pharma N.V. (SIX: IGPH) today announced a refocusing on its industrial process segment.
Pursuant to the new board of directors in office since end of April 2023, the expected setup of an own industrial center for transforming CBD and other vegeta [ … ]
Tue, 30.05.2023
IGEA Pharma N.V.
IGEA to update on strategic refocusing decisions.
Hoofddorp, the Netherlands, 30 May 2023. IGEA Pharma N.V. (SIX: IGPH) today announced a refocusing on its industrial process segment.
Pursuant to the new board of directors in office since end of April 2023, the expected setup of an own industrial center for transforming CBD and other vegeta [ … ]
Mon, 15.05.2023
IGEA Pharma N.V.
IGEA to update on unaudited key figures and ongoing matters
Hoofddorp, the Netherlands, 15 May 2023. IGEA Pharma N.V. (SIX: IGPH) today announced the disclosure of unaudited key figures (as anticipated on 30 April 2023) and certain other ongoing matters as follow:
the group did not start to generate revenue in the industrial process segment [ … ]
Mon, 15.05.2023
IGEA Pharma N.V.
IGEA to update on unaudited key figures and ongoing matters
Hoofddorp, the Netherlands, 15 May 2023. IGEA Pharma N.V. (SIX: IGPH) today announced the disclosure of unaudited key figures (as anticipated on 30 April 2023) and certain other ongoing matters as follow:
the group did not start to generate revenue in the industrial process segment [ … ]
Mon, 01.05.2023
IGEA Pharma N.V.
IGEA to get SIX approval to Annual Report 2022 disclosure
Hoofddorp, the Netherlands, 30 April 2023. IGEA Pharma N.V. (SIX: IGPH) today announced the grant of a temporary exemption from its disclosure obligations with respect to the 2022 Annual Report.
In accordance with SIX’s approval, this press release sets out the relevant secti [ … ]
Mon, 01.05.2023
IGEA Pharma N.V.
IGEA to get SIX approval to Annual Report 2022 disclosure
Hoofddorp, the Netherlands, 30 April 2023. IGEA Pharma N.V. (SIX: IGPH) today announced the grant of a temporary exemption from its disclosure obligations with respect to the 2022 Annual Report.
In accordance with SIX’s approval, this press release sets out the relevant secti [ … ]
Sun, 30.10.2022
IGEA Pharma N.V.
IGEA DISCLOSES ITS HALF-2022 FINANCIAL REPORT
Hoofddorp, the Netherlands, 30 October 2022. IGEA Pharma N.V. (SIX: IGPH) today announced the disclosure of its Half-2022 Financial Report.
Highlights
The Group generated marginal revenues (Keur 5,7) during the first six months of 2022 (previous period: Keur 18,2);
Cost of sales were Keur 5,6 (pr [ … ]
Sun, 30.10.2022
IGEA Pharma N.V.
IGEA DISCLOSES ITS HALF-2022 FINANCIAL REPORT
Hoofddorp, the Netherlands, 30 October 2022. IGEA Pharma N.V. (SIX: IGPH) today announced the disclosure of its Half-2022 Financial Report.
Highlights
The Group generated marginal revenues (Keur 5,7) during the first six months of 2022 (previous period: Keur 18,2);
Cost of sales were Keur 5,6 (pr [ … ]
Thu, 20.10.2022
IGEA Pharma N.V.
IGEA DISCLOSES ITS 2021 ANNUAL REPORT
Hoofddorp, the Netherlands, 20 October 2022. IGEA Pharma N.V. (SIX: IGPH) today announced the disclosure of its 2021 Annual Report.
Highlights
The Group generated marginal revenues of Keur 103,3 for the year ended 31 December 2021 (previous year: Keur 123,7) due to the ongoing efforts to establish market [ … ]